Creative Biolabs-Immuno-oncology

Anti-CD22 (clone IOCR27) SynExpress E1-YF-TF2-X CD4+ T Cells (CAT#: ITS-1124-CR495)

DatasheetDatasheet
Description
This product utilizes CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone IOCR27). We employs the Retrovirus (EF1α-YFP-TFIIB-XbaI) vector components and the SynExpress system of the exons RNA Editing/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD22
Clone
IOCR27
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
YFP
Promoter
EF1α
Effector Gene
TFIIB
Insertion Sites
XbaI
Gene Modification
RNA Editing
Modification Domain
Exons
Carrier Type
Retrovirus
Transformation Accuracy
0.86
Cell Culture
Adherent Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.